Founded to explore the potential of a unique dissolvable hydrogel technology invented at Northeastern University, Quad Technologies is disrupting cell separation and cell therapy workflows by providing cell biologists with a simple, cell-friendly capture and release technology for cell isolation. A primary focus is on developing best-in-class cell separation reagents for immuno-oncology and translational medicine applications. Promising areas of translational medical research today require scientists to isolate and grow pure, healthy cell populations from complex starting materials such as blood and tissue. Most current approaches used to isolate and purify cell populations are associated with low cell viability, low recovery efficiency and undesirable phenotypic changes due to retained magnetic labels on the cells, leftover from the cell separation process. Quad Technologies is improving existing cell separation tools by leveraging our novel QuickGel technology platform to provide drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.